Sage Journals: Discover world-class research

Retricted access

Research article

First published 2026

Evidence supporting European Medicines Agency drug approvals (2020–2023): A cross-sectional study of trial design and outcomes

Maximilian Siebert, Laura Caquelin, Florian Naudet [...]

Clinical Trials

Retricted access

Research article

First published 2024-02

Report of the European Medicines Agency Conference on RNA-Based Medicines

Falk Ehmann, Andreas Kuhn, Anna Maria Gerdina Pasmooij [...]

Nucleic Acid Therapeutics

Open access

Research article

First published 2022-11

Can independent regulatory agencies mend Europe’s democracy? The case of the European Medicines Agency’s public hearing on Valproate

Matthew Wood

The British Journal of Politics and International Relations

Retricted access

Other

First published 1999-10

The European Agency for the Evaluation of Medicinal Products' Centralized Procedure for Product Approval: Current Status

Elaine M. Healy, Kenneth I. Kaitin

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2013-06

The Committee for Advanced Therapies' of the European Medicines Agency Reflection Paper on Management of Clinical Risks Deriving from Insertional Mutagenesis

Alessandro Aiuti, Giulio Cossu, Pablo de Felipe [...]

Human Gene Therapy Clinical Development

Open access

Research article

First published 2021-6

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports

Stefania Chiappini, Fabrizio Schifano, John Martin Corkery [...]

Journal of Psychopharmacology

Open access

Article commentary

First published 2021-10

Is Hospital Exemption an Alternative or a Bridge to European Medicines Agency for Developing Academic Chimeric Antigen Receptor T-Cell in Europe? Our Experience with ARI-0001

Manel Juan, Julio Delgado, Gonzalo Calvo [...]

Human Gene Therapy

Retricted access

Research article

First published 2005-2

The European Medicines Agency: Preparing the ground for the future

Thomas Lönngren

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2012-04

European Medicines Agency Issues Pharmacogenetics Guidance

Biotechnology Law Report

Retricted access

Other

First published 2008-1

Assessing the Performance of the EMEA's Centralized Procedure: A Comparative Analysis with the US FDA

Laura B. Faden, Kenneth I. Kaitin

Therapeutic Innovation & Regulatory Science

Search results